These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1411 related items for PubMed ID: 21534886

  • 1. Antiretroviral use during pregnancy for treatment or prophylaxis.
    Sturt AS, Read JS.
    Expert Opin Pharmacother; 2011 Aug; 12(12):1875-85. PubMed ID: 21534886
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [Abstract] [Full Text] [Related]

  • 6. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida.
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [Abstract] [Full Text] [Related]

  • 7. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK, NISDI Perinatal Study Group.
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [Abstract] [Full Text] [Related]

  • 8. [Revised guideline "Antiretroviral Treatment"].
    Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren.
    Ned Tijdschr Geneeskd; 2005 Oct 22; 149(43):2399-405. PubMed ID: 16277129
    [Abstract] [Full Text] [Related]

  • 9. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L, Marazzi MC, Voetberg A, Magid NA.
    AIDS; 2007 Jul 22; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 22; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 11. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R, Senise J, Vaz M, Diaz R, Castelo A.
    HIV Med; 2009 Mar 22; 10(3):157-62. PubMed ID: 19245537
    [Abstract] [Full Text] [Related]

  • 12. Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States.
    Jamieson DJ, Clark J, Kourtis AP, Taylor AW, Lampe MA, Fowler MG, Mofenson LM.
    Am J Obstet Gynecol; 2007 Sep 22; 197(3 Suppl):S26-32. PubMed ID: 17825647
    [Abstract] [Full Text] [Related]

  • 13. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ, Nesheim S.
    Clin Perinatol; 2010 Dec 22; 37(4):825-42, x. PubMed ID: 21078453
    [Abstract] [Full Text] [Related]

  • 14. HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: a prospective observational study.
    Ha TT, Anh NM, Bao NH, Tuan PL, Caridha R, Gaseitsiwe S, Hien NT, Cam PD, Ehrnst A.
    Scand J Infect Dis; 2012 Nov 22; 44(11):866-73. PubMed ID: 22803820
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS, Losso MH, Salomón H, Harris DR, Pampuro S, Soto-Ramirez LE, Duarte G, de Souza RS, Read JS, NISDI Perinatal Study Group.
    AIDS; 2007 Jan 11; 21(2):199-205. PubMed ID: 17197811
    [Abstract] [Full Text] [Related]

  • 18. Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
    Mirochnick M, Best BM, Clarke DF.
    Clin Perinatol; 2010 Dec 11; 37(4):907-27, xi. PubMed ID: 21078458
    [Abstract] [Full Text] [Related]

  • 19. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D, Cargnel A.
    Scand J Infect Dis Suppl; 2003 Dec 11; 106():70-4. PubMed ID: 15000589
    [Abstract] [Full Text] [Related]

  • 20. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM, Centers for Disease Control and Prevention, U.S. Public Health Service Task Force.
    MMWR Recomm Rep; 2002 Nov 22; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.